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ABSTRACT 
 
For long duration missions outside of the protection of 
the Earth’s magnetic field, exposure to solar particle 
events (SPEs) is a major safety concern for crew 
members during extra-vehicular activities (EVAs) on the 
lunar surface or Earth-to-moon or Earth-to-Mars transit. 
The large majority (~90%) of SPEs have small or no 
health consequences because the doses are low and the 
particles do not penetrate to organ depths.  However, 
there is an operational challenge to respond to events of 
unknown size and duration. We have developed a 
probabilistic approach to SPE risk assessment in support 
of mission design and operational planning.  Using the 
historical database of proton measurements during the 
past 5 solar cycles, the functional form of hazard 
function of SPE occurrence per cycle was found for non-
homogeneous Poisson model.  A typical hazard function 
was defined as a function of time within a non-specific 
future solar cycle of 4000 days’ duration.  Distributions 
of particle fluences for a specified mission period were 
simulated ranging from its 5th to 95th percentile.  Organ 
doses from large SPEs were assessed using NASA’s 
Baryon transport model, BRYNTRN.  The SPE risk was 
analyzed with the organ dose distribution for the given 
particle fluences during a mission period.  In addition to 
the total particle fluences of SPEs, the detailed energy 
spectra of protons, especially at high energy levels, were 
recognized as extremely important for assessing the 
cancer risk associated with energetic particles for large 
events.  The probability of exceeding the NASA 30-day 
limit of blood forming organ (BFO) dose inside a typical 
spacecraft was calculated for various SPE sizes.  This 
probabilistic approach to SPE protection will be 
combined with a probabilistic approach to the 
radiobiological factors that contribute to the uncertainties 
in projecting cancer risks [1, 2] in future work. 
 
1. INTRODUCTION 
 
The risk of radiation-caused cancer and degenerative 
disease as well as acute radiation syndrome raises major 
concerns for astronauts’ safety during space missions 
away from the protective zone of low-earth orbit [1, 2].  
Solar particle events (SPEs) occur quite often and it is 
difficult to predict their onset and size.  Most SPEs 
would result in small doses for the crew even with 
minimal spacecraft or spacesuit shielding, and only a 
small proportion (about 10%) of individual SPEs would 
be of concern to astronauts.  However, the sum doses of 
many small events can disrupt mission operations and 
lead to excessive costs.  
 
For longer duration space missions, chronic exposure to 
SPEs with intense particle fluxes and high energy levels 
is a major concern.  However, the risk of early effects is 
expected to be small, due to the reduction of effects at 
the characteristic dose-rates of SPEs behind protective or 
tissue shielding (<0.3 Gy/h).  However, a significant 
cancer risk does remain for some events [1-4].  As there 
are limitations in crew return vehicles, as well as the 
dose limits defined by NASA [5], accurate estimations of 
SPE frequencies and exposure levels during mission 
periods are necessary for protection of astronauts and for 
determining shielding requirements [4] for missions to 
the Moon and Mars.  A probabilistic risk assessment 
approach is needed to implement the requirements for 
radiation protection from SPEs for astronauts and/or 
possible hardware failures. 
 
Major SPEs were detected on Earth using a variety of 
measuring techniques during solar cycle 19, and since 
the solar cycle 20, SPEs have been routinely detected by 
satellites.  The cumulative frequency curve was derived 
from the event-integrated fluences with energy above 30 
MeV (Φ30) without considering the event onset time.  
Using the 370 SPEs from all available recorded 
databases for solar cycles 19-23, we have developed a 
probabilistic modeling approach, where the best 
propensity for SPE occurrence as a function of time 
within a solar cycle was defined from a non-
homogeneous Poisson model [6].  From the fitted model, 
the expected frequency of SPEs during a defined space 
mission period was estimated and its total proton fluence 
distribution of Φ30 was simulated with a random draw 
from a Gamma distribution for the given mission period. 
 
For SPE risk analysis, analytic representations of energy 
spectra extending over broad energy ranges out to 1 GeV 
were fitted by Weibull-distributions to proton fluence 
measurements.  The defined differential energy spectra 
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of SPEs are propagated through spacecraft and body 
tissue to a typical blood forming organ (BFO) site by 
using the Baryon transport code, BRYNTRN [7, 8].  The 
resultant BFO dose distribution from 34 historically large 
SPEs for an astronaut inside a moderately shielded 
spacecraft has been used for the analysis of BFO 
exposure level during a specific mission period.  The risk 
assessment was made ranging from its 5th to 95th 
percentile with respect to the corresponding Φ30 fluence 
distribution.  The probabilities of BFO doses exceeding 
the NASA recommended limit, which are functions of 
event size and shielding thickness, were calculated for 
various SPE intensities during transit to Moon/Mars and 
on lunar surface.  The results provide useful guidelines 
for developing protection systems for astronauts during 
future space exploration missions. 
 
Lifetime cancer mortality risk described as risk of 
exposure induced death (REID) is employed by NASA 
as the quantity for implementing the radiation protection 
principle of “As low as reasonably achievable”, 
(ALARA).  With the consideration of detailed shielding 
properties provided by a conceptual lunar habitat model, 
the probabilistic assessments of radiation cancer risk, 
which are dependent on age, gender, and solar 
modulation, were predicted at median and upper 95% 
confidence interval (CI) for various mission durations.  
Using the risk mitigation method for candidate spacecraft 
designs, the proper shielding requirements for crew 
members would be identified for future exploration 
mission scenarios.   
   
2. DATABASE OF PROTON MEASUREMENTS 
OF SOLAR PARTICLE EVENTS 
 
We considered all solar particle events (SPEs) for solar 
cycles 19-21 (1955-1986), and all available flux and 
fluence data assembled in the form of a continuous 
database [9-11].  From 1986 to 2007 (solar cycles 22 and 
23), a SPE list and the Geostationary Operational 
Environmental Satellite (GOES) spacecraft 
measurements of the 5-min average integral proton flux 
were obtained through direct access to NOAA’s National 
Geophysical Data Center (NGDC) [12].  For the 
completeness of the event-size of Φ30 for the past five 
solar cycles, the SPE fluences for solar cycles 19-21 
were taken from the [9-11].  The fluences for cycles 22 
and 23 were calculated using the extensive direct GOES 
satellite particle measurements of integral proton flux 
[12].  Between the years 1561 and 1950, 71 SPEs with 
Φ30> 2×109 protons cm-2 [13, 14] were also identified 
from impulsive nitrate enhancements in polar ice cores.  
Tab. 1 lists all of the available data for SPEs for the 
omnidirectional proton fluence of ΦE, where E=10, 30, 
50, 60 or 100 MeV. 
 
Table 1.  Database of recorded SPEs 
Solar 
Cycle 
# of 
SPE 
# of 
Day Period ΦE 
Cycle 23 92 4262 5/1/1996- 12/31/2007* 
Φ10,30,50,60,100 
[12] 
Cycle 22 77 3742 2/1/1986- 4/30/1996 
Φ10,30,50,60,100 
[12] 
Cycle 21 70 3653 2/1/1976- 1/31/1986 Φ10,30 [9] 
Cycle 20 63 4140 10/1/1964- 1/31/1976 
Φ10,30 [9] and 
Φ10,30,60 [10] 
Cycle 19 68 3895 2/1/1954- 9/30/1964 
Φ10,30,100 [9] 
and Φ10,30 
[11] 
Impulsive 
Nitrate 
Events 
71 390 years 1561-1950 Φ30 [13, 14] 
*The end of Cycle 23 estimated 
 
3. PREDICTION OF SPE FREQUENCY 
  
The total of 370 SPEs identified during solar cycles 19–
23 were statistically significantly different in the overall 
distribution of Φ30 from cycle to cycle.  However, 
fluence data of Φ30 was combined over all 5 cycles to 
estimate an overall probability distribution of an average 
cycle.  Fig. 1 shows sample cumulative tail probabilities 
of Φ30 for cycles 19-23 and the overall cumulative tail 
probability (thick line).  Also included in Fig. 1 are the 
probabilities of the impulsive nitrate events of 71 SPEs 
with Φ30 > 2×109 protons cm-2 [13] with and without 
seasonal correction, and they are not significantly 
different from the modern sets of large Φ30 data [6]. 
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Figure 1.   Probability (P) of an SPE event exceeding the 
displayed threshold Φ30. 
 
While the expected frequency of SPEs is strongly 
influenced by solar modulation, the SPE occurrences 
themselves are random in nature.  The "spikes" in Fig. 2 
show the onset times of all SPEs in solar cycles 19-23.  
Because there are typically more SPEs near the middle of 
cycles than near the beginning and end of cycles, the 
hazard function should take on relatively low values at 
the ends of each solar cycle and reach a peak somewhere 
near the middle of cycles.  After studying different 
models for the hazard function and assessing goodness of 
fit, the functional form best explaining all SPEs was 
found as in [6] 
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for a “typical” nonspecific cycle of 4000 days duration (0 
< t < 4000), where λ0, K, p, and  q are parameters to be 
estimated.  Resulting maximum-likelihood parameter 
estimates were λ0 = 19.52, K = 55.89, p = 4.073 and q = 
4.820.  Also, from eqn (1), it can be shown that μ, the 
time of peak hazard, is 4000(p – 1)/(p + q –2) days into a 
cycle.  For the observed data, μ was estimated at 1783 
days.   
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Figure 2.  The onset dates of SPEs occurring between 
January 1, 1956 and December 31, 2007. 
 
Using the basic properties of a Poisson process and the 
estimated λ(t) at time t of a solar cycle, the expected 
number of events for a mission in a time interval (t1, t2), 
N(t1, t2) were estimated more accurately than obtained by 
simple counting of cases in the SPE data occurred in a 
given time period (t1, t2).  For conservatism, missions 
were assumed to take place centered on the time of 
greatest hazard, μ = 1783 days into a solar cycle, so that 
t1 = 1783 – d/2 and t2 = 1783 + d/2, where d is mission 
length (days).   
 
4. SIMULATION OF THE EVENT SIZE 
DISTRIBUTION 
 
There isn’t any recognizable pattern of the event size 
distribution during the past 5 solar cycles and the event 
size Φ30 is independent of elapsed time between two 
consecutive events [6].  Therefore, the individual event 
size Φ30 for each SPE occurrence must be independent of 
the expected number of events for a given mission 
duration, N(d).   For the randomness of individual event 
size, its Φ30 was simulated with a random draw from a 
Gamma distribution.  An empirical distribution of total 
fluence Φ30 ranging from the 5th to 95th percentile is 
shown in Fig. 3 for a range of potential mission lengths. 
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Figure 3.  Simulated distribution of Φ30. 
 
5. CONTINUOUS ENERGY SPECTRUM OF SPE 
FOR RISK ANALYSIS   
 
With the expected number of events, which took into 
account for the randomness of SPE occurrences, total 
event sizes of Φ30 in a mission period have been 
simulated ranging from its 5th to 95th percentile.  The 
intense SPEs were considered as potentially debilitating 
events.  In assessing radiation risk from SPEs during a 
given mission period, the simulation must take into 
account not only the randomness of SPE occurrences and 
event sizes of Φ30, but also the variation of energy 
spectra for the SPEs, because the detailed SPE energy 
spectrum is the important parameter.  
 
For the continuous fluence-energy spectrum of SPE, 
each SPE must be characterized from the individual 
measurements.  Time-integrated integral proton fluence 
measurements of SPEs are available at discrete energies 
usually with >10, >30, >50, >60, or >100 MeV as listed 
in Tab. 1.  Data at energies higher than 100 MeV are 
rather limited, and extrapolation to higher energies based 
on the spectral shape of individual SPE is necessary.  A 
number of approaches to determine the spectral 
parameters have been reported [15-21].   Two fits, 
exponential rigidity and the Weibull distribution, are 
shown in Fig. 4 for the measurements of October 19, 
1989 SPE, in which the measured spectrum extends to 
energies out to 100 MeV range.  The continuous energy 
spectrum fitted by the Weibull parameterization shows to 
be accurate with the existing measurements of proton 
fluence at lower energies.  Therefore, Weibull 
distribution spectral parameters for 34 historically large 
SPEs in the space era [17] were used for the current risk 
assessments from SPEs. 
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Figure 4.  Fit to proton fluence measurements for 
continuous energy spectrum of October 19, 1989 SPE. 
 
Radiation transport properties of shielding materials and 
the astronaut’s body tissues were calculated using 
NASA’s BRYNTRN code [7, 8].  The shielding 
distribution of the spacecraft was initially represented as 
a 5 g/cm2-thick sphere of aluminum representing the 
equipment room of the vehicle.  The body shielding 
distribution at the sensitive organ sites was obtained 
using the computerized anatomical man (CAM) model 
[22].  The resultant blood forming organ (BFO) doses 
from 34 large SPEs are shown in Fig. 5 (filled square).  
The solid line is the linear regression fit of BFO dose as 
a function of event size of Φ30 on a log-log scale.  A SPE 
above the regression line is considered to be a “hard” 
spectrum (e.g., July 1961 SPE), on or very near the line 
as “median” spectrum (e.g., August 1972 SPE, October 
1992 SPE, and April 2002 SPE), and below the line as a 
“soft” spectrum for any event of fluence Φ30.  For each 
event and corresponding fluence in Fig. 5, the BFO dose 
distribution is simulated by a random draw from a 
normal distribution about the regression line, which is 
attributable to the variability of SPE spectra.  The 
vertical lines in Fig. 5 represent a range from the 5th to 
the 95th percentile of the distribution of the BFO dose, 
which results from the variability of the SPE spectra of 
the same event size Φ30.  Also, included in Fig. 5 as a 
horizontal dashed line is the current NASA 30-day BFO 
dose limit [23] of 25 cGy-Eq.  Using this fitted 
regression model, the probability of exceeding the 
NASA 30-day limit dose was calculated as a function of 
Φ30 for an aluminum vehicle with 5 or 10 g/cm2-
thickness located in interplanetary space or on the lunar 
surface.  These are shown in Fig. 6. 
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Figure 5.  BFO dose of 34 large SPEs inside an 
equipment room in interplanetary space. 
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Figure 6.  Probability of exceeding the NASA 30-d limit 
of BFO dose as a function of Φ30, shield, and location. 
 
6. ORGAN DOSE AND PROBABILISTIC 
ASSESSMENT OF CANCER RISK WITH 
CONCEPTUAL LUNAR HABITAT 
 
Organ dose calculations were made with the CAM model 
[22], which represents the self-shielding of the human 
body in a water equivalent mass approximation.  The 
whole body effective dose is defined as a summation 
over radiation types and organ/tissues using the tissue 
weighting factors, wT [24].   
 
The amount of directional shielding offered by all of the 
structural components and contents of the vehicle, such 
as various racks, equipment, and inner and outer shell 
materials of a conceptual lunar habitat design1, was 
accounted for in the radiation risk assessment at specific 
positions of the storm shelter and living area.  The storm 
shelter was located in the sleep area, in which 10 g/cm2 
of water wall shields were added to the outer upper wall 
and the side upper wall.  It added a total of 623 kg of 
                                                 
1 Credit to G. Qualls at NASA Langley Research Center for ray tracing 
of conceptual lunar habitat design. 
water weight to the habitat.  The event-specific whole 
body effective doses are presented in Tab. 2 for the storm 
shelter and living area inside the lunar habitat for various 
SPE spectra, including the Weibull distribution of the 
July 1961 SPE hard spectrum, three other Weibull 
distributions as median spectra, and the King spectrum of 
August 1972 SPE as a design standard recommended in 
[23].  
 
 
Table 2.  Whole body effective dose from each SPE at two 
positions inside a conceptual lunar habitat. 
SPE 
Weibull Distribution
Φ30, 
p/cm-2 
Effective dose, mSv 
Strom shelter Living area 
Male Female Male Female 
7/18/1961 3x108 9.2 9.3 17.5 17.5 
4/21/2002 2.72x108 1.9 1.9 6.7 6.4 
10/30/1992 7.27x108 6.8 6.8 17.9 17.3 
8/2/1972 8.1x109 67.6 66.9 234.1 221.7 
Aug 1972 
King Spec 8.1x10
9 58.88 57.4 234.7 219.6 
 
 
Whole body effective doses for the given mission 
periods were calculated by scaling the SPE fluence with 
its specific spectral variation to the total SPE fluences of 
Φ30 at median and upper 95% confidential interval for 90 
and 365 day lunar missions (Tab. 3 and 4, respectively).  
From these results, the King Spectrum of the August 
1972 SPE is recognized as a design standard for the 
cancer risk assessment in this study, because it 
reasonably represents SPE spectral variability of the 
median level events. 
 
 
Table 3.  Whole body effective dose from total SPE fluence for 
90-d lunar mission 
(a) SPE at Median 
SPE Φ30 Scale 
Effective dose at Median 
SPE for 90-d, mSv 
Strom 
shelter Living area 
M F M F 
7/18/1961 6.2x107 0.21 1.90 1.92 3.62 3.62 
4/21/2002 6.2x107 0.23 0.43 0.43 1.53 1.46
10/30/1992 6.2x107 0.09 0.58 0.58 1.53 1.48 
8/2/1972 6.2x107 0.01 0.52 0.51 1.79 1.70 
Aug 1972 
King Spec 6.2x10
7 0.01 0.45 0.44 1.80 1.68 
 
 
(b) SPE at upper 95% CI 
SPE Φ30 Scale 
Effective dose at  
Upper 95% CI SPE 
for 90-d, mSv 
Strom  
shelter 
Living 
 area 
M F M F 
7/18/1961 1.0x1010 33.33 307 310 583 583 
4/21/2002 1.0x1010 36.76 70 70 246 235 
10/30/1992 1.0x1010 13.76 94 94 246 238 
8/2/1972 1.0x1010 1.23 84 83 289 274 
Aug 1972 
King Spec 1.0x10
10 1.23 73 71 290 271 
 
 
Table 4.  Whole body effective dose from total SPE fluence for 
365-d lunar mission. 
(a) SPE at Median 
SPE Φ30 Scale 
Effective dose at Median 
SPE for 365-d, mSv 
Strom 
shelter Living area 
M F M F 
7/18/1961 1.06x109 3.53 32.5 32.9 61.8 61.8 
4/21/2002 1.06x109 3.90 7.4 7.4 26.1 24.9 
10/30/1992 1.06x109 1.46 9.9 9.9 26.1 25.2 
8/2/1972 1.06x109 0.13 8.9 8.8 30.6 29.0
Aug 1972 
King Spec 1.06x10
9 0.13 7.7 7.5 30.7 28.7 
 
 
(b) SPE at Upper 95% CI  
SPE Φ30 Scale 
Effective dose at  
Upper 95% CI SPE 
for 365-d, mSv 
Strom  
shelter 
Living 
 area 
M F M F 
7/18/1961 1.89x1010 63.00 580 586 1103 1103 
4/21/2002 1.89x1010 69.49 132 132 466 445 
10/30/1992 1.89x1010 26.00 177 177 466 450 
8/2/1972 1.89x1010 2.33 158 156 546 517 
Aug 1972 
King Spec 1.89x1010 2.33 137 134 548 512 
 
 
Career exposure to radiation is limited by NASA so as 
not to exceed 3% risk of exposure induced death (REID) 
from fatal cancer.  NASA policy is to assure that this risk 
limit is not exceeded at the 95% confidence level, using a 
statistical assessment of the uncertainties in the risk 
projection calculations to limit the cumulative effective 
dose (in units of Sievert) received by an astronaut 
throughout his or her career.  These limits are applicable 
to missions in low Earth orbit (LEO) of any duration, and 
to lunar missions of less than a certain number of days.  
Non-cancer mortality risks and approaches to reducing 
uncertainties in cancer risk projection models must be 
considered further for longer missions outside LEO. 
 
The relationship between radiation exposure and risk is 
both age and gender specific, due to latency effects, and 
to differences in tissue types, sensitivities, and life-span 
expectations.  These relationships are estimated using the 
methods recommended by the NCRP [5], and more 
recent radiation epidemiology research [26, 27].  The 
cancer fatality risk (%REID) to an astronaut during a 
space mission is found by applying the double-detriment 
life table using the tissue-weighted effective dose, E, and 
time-dependent relative risk functions [4].  
 
The current NASA model [5] was based on life-span 
studies (LSS) of atomic bomb survivors, since the doses 
received by the LSS population overlap strongly with the 
doses of concern to NASA exploration missions [26].  
The most recent and extensive review of data sets from 
human populations, including nuclear reactor workers 
and patients treated with radiation, was reported in 
Biological Effects of Ionizing Radiation (BEIR) VII 
[27].  Cancer fatality risk of %REID as functions of age 
at exposure, gender, and solar cycle dependence was 
calculated using two projection models for various lunar 
mission periods: in Tab. 5a for the missions at solar 
maximum, and in Tab. 5b for those at solar minimum. 
 
 
Table 5a.  Cancer fatality risk of %REID at solar maximum 
  90-d mission 180-d mission 365-d mission Male Female Male Female Male Female 
Effective dose at 
median, mSv 
 
35.4 35.7 72.1 72.6 149.4 150.3 
Effective dose at 
upper 95% CI 107.6 106.1 157.1 155.5 279.1 276.7 
%REID 
Carcino-
genesis 
Age, yr NASA Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
NASA 
Model 
BEI
R-
VII 
Median  
35 0.14 0.14 0.17 0.19 0.28 0.27 0.35 0.38 0.57 0.56 0.71 0.78 
40 0.12 0.13 0.15 0.19 0.25 0.27 0.31 0.38 0.52 0.55 0.63 0.77 
45 0.11 0.13 0.13 0.18 0.22 0.26 0.26 0.37 0.45 0.53 0.54 0.75 
50 0.09 0.12 0.11 0.17 0.19 0.25 0.22 0.36 0.38 0.51 0.46 0.72 
55 0.08 0.12 0.09 0.16 0.16 0.24 0.19 0.33 0.33 0.48 0.38 0.68 
Upper 
95% CI 
35 1.1 1.1 1.3 1.5 1.7 1.7 2.1 2.3 3.2 3.1 3.9 4.2 
40 1.0 1.1 1.2 1.5 1.6 1.7 1.9 2.3 2.8 3.0 3.4 4.2 
45 0.9 1.0 1.0 1.4 1.3 1.6 1.6 2.2 2.5 2.9 2.9 4.1 
50 0.7 1.0 0.9 1.4 1.2 1.5 1.4 2.2 2.1 2.8 2.5 3.9 
55 0.6 0.9 0.7 1.3 1.0 1.5 1.2 2.0 1.8 2.6 2.1 3.7 
 
 
Table 5b.  Cancer fatality risk of %REID at solar minimum 
  90-d mission 180-d mission 365-d mission Male Female Male Female Male Female 
Effective dose, 
mSv 76 76 152 152 304 305 
%REID 
Carcino-
genesis 
Age, yr NASA Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
NASA 
Model 
BEIR-
VII 
Median  
35 0.29 0.28 0.29 0.4 0.58 0.57 0.72 0.79 1.16 1.13 1.44 1.58 
40 0.26 0.28 0.26 0.39 0.52 0.56 0.64 0.78 1.04 1.11 1.27 1.56 
45 0.23 0.27 0.23 0.38 0.45 0.54 0.54 0.76 0.90 1.08 1.08 1.52 
50 0.19 0.26 0.19 0.37 0.39 0.52 0.46 0.73 0.78 1.04 0.92 1.46 
55 0.17 0.25 0.17 0.35 0.33 0.49 0.39 0.69 0.66 0.98 0.77 1.37 
Upper 
95% CI 
35 1.1 1.1 1.1 1.6 2.3 2.3 2.8 3.1 4.6 4.5 5.7 6.2 
40 1.0 1.1 1.0 1.5 2.1 2.2 2.5 3.1 4.1 4.4 5 6.2 
45 0.9 1.1 0.9 1.5 1.8 2.1 2.1 3.0 3.6 4.3 4.3 6.0 
50 0.8 1.0 0.8 1.5 1.5 2.1 1.8 2.9 3.1 4.1 3.6 5.8 
55 0.7 1.0 0.7 1.4 1.3 1.9 1.5 2.7 2.6 3.9 3.0 5.4 
 
 
7.  CONCLUSION 
 
For managing space radiation risk in the new era of 
space exploration, the sporadic distribution of SPE 
occurrences in a given mission period was analyzed by 
employing a probabilistic approach using data from all 
the recorded SPEs.  This model-based estimate has 
shown to be considerably more accurate than one based 
on simple counting of historical events, of which there 
may be very few within the time window.  Next, the 
distribution of total fluences of SPEs in a given mission 
period was simulated by a random draw from Gamma 
distribution due to the randomness of individual event 
size.  The exposure risk from each event with its 
corresponding fluence is distributed as a normal 
distribution about the regression line, which is 
attributable to the variability of detailed SPE spectra, by 
which probability of exceeding the current NASA limit 
can be calculated for the guidelines in developing 
spacecraft design.  In assessing radiation risk from SPEs 
for a range of potential mission lengths, the simulation 
took into account not only the randomness of SPE 
occurrences and individual event sizes, but also the 
variability of SPE energy spectra.  Based on the 
probabilistic assessment of radiation risk of a conceptual 
lunar habitat model, lunar missions up to 210-day are 
allowed at solar maximum, but those to 90-day are 
allowed at solar minimum, because the fatal cancer risks 
for astronauts during those mission periods are within the 
maximum acceptable levels of 3% at the upper 95% 
confidence interval.  The results will be useful in 
developing guidelines for protection systems for 
astronauts during future space exploration missions. 
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